User profiles for YI-HSIN LIANG
Yi-Hsin LiangDepartment of Oncology, National Taiwan University Hospital, Taipei City, Taiwan Verified email at ntuh.gov.tw Cited by 140 |
[HTML][HTML] Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing
Single immunotherapy fails to demonstrate efficacy in patients with microsatellite stable (MSS)
metastatic colorectal cancer (mCRC). Research on immune reactions before and after …
metastatic colorectal cancer (mCRC). Research on immune reactions before and after …
[HTML][HTML] Taiwan society of colon and rectal surgeons consensus on mCRC treatment
…, YY Hsieh, HW Teng, BW Lin, YH Liang… - Frontiers in …, 2021 - frontiersin.org
Therapeutic options for metastatic CRC (mCRC) have changed significantly in recent years,
greatly increasing the complexity of therapeutic decision-making. Although oncology …
greatly increasing the complexity of therapeutic decision-making. Although oncology …
A randomized, double-blind, phase III study comparing trifluridine/tipiracil hydrochloride therapy versus placebo in resected colorectal cancer patients who are positive …
…, M Shiozawa, A Kanazawa, I Takemasa, YH Liang… - 2022 - ascopubs.org
TPS215 Background: Circulating tumor DNA (ctDNA) can be used to predict the risk of recurrence
by detecting molecular residual disease (MRD) in patients with colorectal cancer (CRC…
by detecting molecular residual disease (MRD) in patients with colorectal cancer (CRC…
[HTML][HTML] Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells
YH Liang, KH Chen, JH Tsai, YM Cheng… - Journal of biomedical …, 2021 - Springer
Background A new strategy, particularly a novel combination, for immunotherapy in microsatellite
stable metastatic colorectal cancer (mCRC) treatment needs to be formulated. Studies …
stable metastatic colorectal cancer (mCRC) treatment needs to be formulated. Studies …
[HTML][HTML] Cytotoxic chemotherapy as first-line therapy for advanced non-small-cell lung cancer in Taiwan: Daily practice
Aim: Cytotoxic chemotherapy is the standard first-line therapy for patients with advanced non-small
cell lung cancer (NSCLC) without specific gene alterations. This study examined the …
cell lung cancer (NSCLC) without specific gene alterations. This study examined the …
[HTML][HTML] Oxaliplatin-Based Chemotherapy Is More Beneficial in KRAS Mutant than in KRAS Wild-Type Metastatic Colorectal Cancer Patients
YL Lin, YH Liang, JH Tsai, JY Liau, JT Liang, BR Lin… - PloS one, 2014 - journals.plos.org
To identify better regimens in currently available chemotherapy would be beneficial to KRAS
mutant metastatic colorectal cancer (mCRC) patients because they have fewer treatment …
mutant metastatic colorectal cancer (mCRC) patients because they have fewer treatment …
Do-not-resuscitate consent signed by patients indicates a more favorable quality of end-of-life care for patients with advanced cancer
YH Liang, CH Wei, WH Hsu, YY Shao, YC Lin… - Supportive Care in …, 2017 - Springer
Purpose Do-not-resuscitate (DNR) consent is crucial in end-of-life (EOL) care for patients
with advanced cancer. However, DNR consents signed by patients (DNR-P) and surrogates (…
with advanced cancer. However, DNR consents signed by patients (DNR-P) and surrogates (…
Irinotecan and oxaliplatin might provide equal benefit as adjuvant chemotherapy for patients with resectable synchronous colon cancer and liver-confined metastases …
YH Liang, YY Shao, HM Chen, AL Cheng… - Anticancer …, 2017 - ar.iiarjournals.org
Background: Although irinotecan and oxaliplatin are both standard treatments for advanced
colon cancer, it remains unknown whether either is effective for patients with resectable …
colon cancer, it remains unknown whether either is effective for patients with resectable …
Disseminated microvascular pulmonary tumor embolism from non-small cell lung cancer leading to pulmonary hypertension followed by sudden cardiac arrest
YH Liang, SW Kuo, YL Lin, YL Chang - Lung Cancer, 2011 - Elsevier
Disseminated microvascular pulmonary tumor embolism (DMPTE) is extremely rare and
invariably fatal. Typical symptoms and signs of DMPTE include shortness of breath and …
invariably fatal. Typical symptoms and signs of DMPTE include shortness of breath and …
Immunotherapy-associated symptoms, distress, financial toxicity and unmet supportive care needs of patients with cancer
YH Lee, CL Siao, HY Yang, YH Lai, YH Liang… - European Journal of …, 2024 - Elsevier
… Yi-Hsin Liang: Supervision, were involved in planning and supervising this work. Yu-Fan
Chen: Investigation, helped to screen for potential participants. Mei-Chih Wu: Investigation, …
Chen: Investigation, helped to screen for potential participants. Mei-Chih Wu: Investigation, …